These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9425892)

  • 21. [Preparation of SYT gene knockout mice and their analysis].
    Kimura T
    Hokkaido Igaku Zasshi; 2005 Jul; 80(4):365-73. PubMed ID: 16107051
    [No Abstract]   [Full Text] [Related]  

  • 22. Loss of Msh2 is not associated with FHIT deletion in breast carcinomas.
    Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(5):2591-5. PubMed ID: 12529969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for mismatch repair in control of DNA ploidy following DNA damage.
    Strathdee G; Sansom OJ; Sim A; Clarke AR; Brown R
    Oncogene; 2001 Apr; 20(15):1923-7. PubMed ID: 11313940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice.
    Kongkanuntn R; Bubb VJ; Sansom OJ; Wyllie AH; Harrison DJ; Clarke AR
    Oncogene; 1999 Dec; 18(51):7219-25. PubMed ID: 10602475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice.
    Manley K; Shirley TL; Flaherty L; Messer A
    Nat Genet; 1999 Dec; 23(4):471-3. PubMed ID: 10581038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
    Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
    Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlling apoptosis: implications for carcinogenesis?
    Clarke AR
    Symp Soc Exp Biol; 2000; 52():265-75. PubMed ID: 12090014
    [No Abstract]   [Full Text] [Related]  

  • 28. Msh2 deficiency increases the mutation frequency in all parts of the mouse colon.
    Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
    Environ Mol Mutagen; 2002; 40(4):243-50. PubMed ID: 12489114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene.
    Baross-Francis A; Milhausen MK; Andrew SE; Jevon G; Jirik FR
    Carcinogenesis; 2000 Jun; 21(6):1259-62. PubMed ID: 10837019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
    Ehrenstein MR; Neuberger MS
    EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
    Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
    Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Coriah MR
    Hum Genet; 2005 May; 116(6):539. PubMed ID: 15991316
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesis.
    Hooker AM; Morley AA; Tilley WD; Sykes PJ
    Mutat Res; 2004 Jun; 550(1-2):1-10. PubMed ID: 15135636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
    Sansom OJ; Stark LA; Dunlop MG; Clarke AR
    Cancer Res; 2001 Oct; 61(19):7060-4. PubMed ID: 11585736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
    Hum Genet; 2005 May; 116(6):538. PubMed ID: 15991315
    [No Abstract]   [Full Text] [Related]  

  • 36. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
    Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
    Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study.
    Young LC; Thulien KJ; Campbell MR; Tron VA; Andrew SE
    Carcinogenesis; 2004 Oct; 25(10):1821-7. PubMed ID: 15166087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
    Hum Genet; 2005 May; 116(6):538. PubMed ID: 15991314
    [No Abstract]   [Full Text] [Related]  

  • 39. P53 null mice: damaging the hypothesis?
    Sansom OJ; Clarke AR
    Mutat Res; 2000 Sep; 452(2):149-62. PubMed ID: 11024475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of recessive lethal genes in spontaneous embryonal lethality in random-bred rat and mouse populations in Cuba].
    Semenov KhKh; Walker D
    Biull Eksp Biol Med; 1983 Mar; 95(3):71-3. PubMed ID: 6830991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.